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Abstract
Background: The main goal of oral vaccination of foxes is eradication of rabies in the red fox population as rabies
reservoirs. To evaluate the success of vaccination a serological testing is conducted as a part of monitoring program.
Two different methods are used regarding rabies serology: virus neutralisation test and ELISA.
Methods: In this study the reliability of BioPro ELISA was evaluated for testing haemolytic thoracic liquids and muscle
extracts originated from 147 foxes in comparison to mFAVN. Also, the influence of heat treatment of samples on test
results was investigated.
Results: The specificity of the test for not-heat treated samples was 92.98 % and sensitivity 79.20 %. Diagnostic validity
of the ELISA compared to the mFAVN test when not-heat treated samples were used was 89.16 %. The specificity of
the test for heat treated samples was 79.10 % and sensitivity 96.36 %. Diagnostic validity of the BioPro ELISA compared
to the mFAVN test for heat treated samples was 94.30 %.
Conclusion: According to this study, the BioPro ELISA is reliable tool for detection of rabies specific antibodies in the
context of evaluation of oral vaccination of foxes from poor quality samples as a substitution for virus neutralisation tests.
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Background
In Europe, the main goal of oral vaccination (ORV) is
eradication of rabies in wildlife [1]. To achieve this object-
ive, oral vaccine baits (vaccine Lysvulpen, Bioveta, Czech
Republic) containing live attenuated rabies virus is used in
Croatia. The ORV of foxes in Croatia was carried out sim-
ultaneously with similar programs in the neighbouring
countries as a part of control and eradication of rabies in
Western Balkan countries co-financed by European Com-
mission [2]. As a part of monitoring, vaccination efficacy
is evaluated considering the rabies incidence, bait uptake
and humoral immune response [1]. This approach showed
very good results in effectiveness of elimination of terres-
trial rabies in Europe [3].
Considering the assessment of vaccination efficiency
the main obstacle in evaluation of humoral response is
the low quality of the samples. The quality of the sam-
ples depends on the sampling procedure. In some coun-
tries the sampling is organised immediately after killing
of foxes, but in most countries the carcasses of foxes are
frozen before sampling. Time between shooting and sam-
pling in the lab can be extended (up to 10 days). In such
case it is difficult to collect serum from the foxes. Conse-
quently, it is not possible to perform serological test and
evaluate humoral immunological response. As a substitu-
tion for the serum, the liquid from thoracic cavity or ex-
tracts of the muscles can be used as samples [4].
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Currently two different methods are used regarding ra-
bies serology: virus neutralisation test and ELISA. Neu-
tralisation tests: fluorescent antibody virus neutralisation
(FAVN) test and rapid fluorescent focus inhibition test
(RFFIT) are known to be the most reliable tests for
evaluation of successful vaccination [5–8]. However, the
neutralisation tests are time consuming, expensive and
require live rabies virus [9]. Also, sometimes the results
cannot be read off due to cytotoxic effect on the cells
[10]. In order to overcome that problem the ELISA has
been developed. Currently two ELISAs for detection of
rabies specific antibodies existed on the European Union
market: Bio-Rad (Platelia Rabies II - Biorad, Marnes-La-
Coquette, France) and BioPro (Prague, Czech Republic).
BioPro ELISA is recently developed test especially de-
signed for the detection of rabies virus antibodies in the
monitoring of the fox ORV campaigns [9]. This test was
evaluated on fresh foxes samples and also on dogs and
cats samples [9, 11] and showed to be a reliable tool for
serological testing. Until now, muscle extracts and poor
quality thoracic liquid samples were not used as samples
for serological testing with virus neutralisation tests. The
main reason for that was cytotoxic effect caused by quality
of the samples. Because of the same reason it was also im-
possible to evaluate ELISA on those samples. Recently, the
new test – modified fluorescent virus neutralisation test
(mFAVN) was developed and problem with cytotoxicity
has been eliminated [4]. Furthermore, according to that
study, very good agreement between antibody titre in dog
sera, thoracic liquids and muscle extracts were recorded.
Those findings allow evaluation of ELISA for the detection
of rabies virus antibodies from the thoracic liquid and
muscle extract samples in the monitoring of fox ORV
campaigns.
This paper evaluates the specificity and sensitivity of
commercial BioPro ELISA kit for the detection of rabies
virus antibodies from the haemolytic thoracic liquid and
muscle extract samples in the monitoring of fox ORV
campaigns. Furthermore, the possibility to improve diag-




All samples were collected by hunters in compliance
with national regulations according to “Order on oral
vaccination of foxes on territory of Republic of Croatia”
[12]. Sampling was performed strictly as a part of pro-
gram “Control and eradication of rabies in Croatia” co-
financed by IPA project (number of project: 2008-0303-
0804). Sampling was approved by ethics committee of
Croatian Veterinary Institute (decision number: Z-VI-4-
2261-1/12).
Samples
The samples were collected from the 147 foxes during
the monitoring of fourth ORV campaign (autumn 2012).
The first choice for sampling was thoracic liquid. How-
ever, in the case that thoracic liquid could not be col-
lected the piece of m. femoralis was taken in order to
obtain muscle extract. So, the muscle and thoracic liquid
samples were never taken from the same animal. There-
fore, from the 55 foxes the fluid from the thoracic cavity
was taken and from 92 foxes the piece of m. femoralis
(approximately 5 × 7 cm) was taken. The carcasses of
foxes were not frozen before sampling. The carcasses
were placed at ambient temperature and sampled 3–4
days post mortem.
The collected haemolytic liquid samples from the
thoracic cavity were centrifuged at 220 × g for 10 min
and the separated liquid was placed in two sterile tubes
and stored at −20 °C until testing. In order to collect
muscle extracts, the muscles in sterile flasks were frozen
at - 20 °C for 4 days and then placed at 4 °C for 3–5
days. From each piece of muscle, a sample approxi-
mately 200–300 μl of the muscle extract was collected,
centrifuged at 220 × g for 10 min, placed in two sterile
tubes and stored at −20 °C prior to analysis. On the day
of testing, from each sample one tube was heat-treated
at 56 °C for 30 min and centrifuged (220 × g). Before
testing, all samples were centrifuged one more time.
The heat treated samples were tested using the both tests:
mFAVN test and BioPro ELISA. The not-heat treated sam-
ples were tested only using the BioPro ELISA. The not-heat
treated samples were not tested with mFAVN test because
in that case unspecific reactions could be observed [13].
Virus neutralisation test
Rabies neutralising antibodies were detected in thoracic
liquids and muscle extracts with the mFAVN as described
previously [4]. In that paper mFAVN test was evaluated
using the dog samples with the cut off 0.5 IU/ml. However,
in this paper instead of the term “positive” (0.5 IU/ml) the
term “threshold of detection” (0.1 IU/ml) in the context of
evaluation of fox ORV was adopted. Because of that, for
the purpose of this study the mFAVN test was compared
with FAVN test on the dog samples as described previously
[4] and evaluated using the cut of 0.1 IU/ml.
ELISA
The rabies antibodies were detected in thoracic liquids
and muscles extracts with the BioPro Rabies ELISA kit ac-
cording to the manufacturer instructions. The BioPro
ELISA is blocking ELISA for detection of rabies virus anti-
bodies in serum or plasma. The wells of microplates are
coated with rabies antigen. Diluted samples are incubated
in the wells. After washing biotinylated anti-rabies anti-
body is added to wells. In the case of positive samples
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specific antibodies will block binding of biotynylated anti-
rabies antibodies with coated rabies antigen. The condi-
tions of validation described by the manufacturer were
implemented to interpret the results obtained for the
samples. The percentage of blocking was calculated for
each sample according to the manufacturer’s specifica-
tions. For checking the effectiveness of ORV campaigns,
the manufacturer was established the threshold of positiv-
ity to 40 %.
Statistical analysis
The true positive and true negative test results were
determined by the mFAVN. Evaluation of ELISA and
results were interpreted according to previous studies
[14, 15]. The validity or degree to which the test mea-
sures what it claims to measure is assessed by area under
ROC curve using STATA 10 (Stata Press, College station,
Texas, USA). The agreement beyond chance level between
the two diagnostic tests (kappa value), and measurements
of the test performance area under the ROC curve were




In this paper complete neutralization at serum dilution
above of 1:4 was corresponding to titer 0.1 IU/ml. The
validation of mFAVN test for difference cut-off was per-
formed using the results from the previous study [4].
The sensitivity and specificity of the mFAVN test com-
pared to FAVN test for difference cut-off are recorded in
Table 1. Diagnostic agreement (when cut-off was set on
0.1 IU/ml in both test) between FAVN and mFAVN tests
of serum was perfect.
BioPro ELISA
To establish the specificity and sensitivity of the ELISA,
147 samples (thoracic liquids and muscle extracts) were
tested in parallel with the mFAVN and ELISA (Table 2).
No cytotoxicity was observed for either type of samples
when mFAVN were used.
The results regarding sensitivity, specificity, diagnostic
agreement and diagnostic validity for either type of sam-
ples are recorded in Table 3. Correlation between titres
of antibodies titrated by mFAVN test and percent of
blocking obtained with BioPro ELISA are recorded in
Figs. 1, 2 and 3.
Discussion
The most effective method for evaluation of ORV cam-
paign success is monitoring program. [1]. Main parts of
program are control of bait uptake (tetracycline detection)
and evaluation of immunological response (detection of
specific antibodies) [16]. The specific rabies antibodies in
the monitoring of fox ORV campaigns can be detected by
using two different methods: virus neutralisation test and
ELISA [16]. ELISA is simpler and faster method but the
virus neutralization test is still considered as a golden
standard. Although the principle of ELISA is different
compared to virus neutralization test for the validation
purpose the ELISA is usually compared with the virus
neutralisation test. However, the possibility of evaluation
depends on quality of samples. The poor quality samples
may prevent the successful performance of virus neutral-
isation test. Because of that ELISA has never been evalu-
ated for detection of antibodies against rabies in muscle
extracts. Recently, the ELISA was evaluated on fresh col-
lected thoracic liquid samples of foxes [11] and on sera
samples of dogs and cats [9].
In this study ELISA was evaluated in the part of ORV
campaigns monitoring as a tool for detection of specific
rabies antibodies in poor quality hemolytic thoracic
liquids and muscle extract samples. For that purpose the
term “threshold of detection” (0.1 IU/ml) was applied
instead of generally accepted adequate immunological
response after vaccination (0.5 IU/ml). As is mentioned
previously [17], because no specific rabies virus neutral-
isation antibodies level can been identified as absolute
protection under all circumstances and in all hosts
against all rabies virus variant infections, antibodies level
attained by the majority of subjects in vaccine clinical
trials formed the basis for the levels currently recognized
as the minimal adequate response in vaccinated humans.
According to World Health Organisation (WHO) that
minimal adequate response is 0.5 [18]. This level was also
adopted from World Organisation for Animal Health
(OIE) as a minimal adequate response in vaccinated ani-
mals [13]. However, according to United States Advisory
Committee on Immunization Practices (US ACIP) the ad-
equate response is if no nonspecific inhibition reactions
Table 1 The sensitivity and specificity for the mFAVN test compared to FAVN test for different cut-offs
Cut-off value Sensitivity Specificity Correctly classified Cumulative AUC
1. 0.100 1.0000 1.0000
2. 0.200 1.0000 1.0000
3. 0.300 1.0000 0.9655 99.0000 0.9976
4. 0.400 0.9706 0.8750 94.0000 0.9910
5. 0.500 0.9440 0.8880 94.0000 0.9900
Bedeković et al. BMC Veterinary Research  (2016) 12:76 Page 3 of 7
were found in serum dilutions above 1:5 [19]. The level
described in the US ACIP is approximately 0.1 IU/ml in
the RFFIT as originally described [20]. Furthermore, the
main point regarding ORV serological monitoring is that
for the purpose of detection of immunological response, a
lower level is better suited than the globally recognized
0.5 IU/ml level for proof of adequate response to vaccin-
ation. Also, according to the previous study [17] the titer
0.1 IU/ml corresponding to a complete neutralisation at
1:5 serum dilution in the RFFIT. However, according to
the same authors this can represent different titers and
IU/ml values in laboratories that perform modified RFFIT
which is the case with the mFAVN test described in this
paper. In addition, United States Department of Agricul-
ture considers an even lower cut-off >50 % neutralization
at the 1:5 serum dilution when evaluating oral vaccination
(~0.05 IU/ml) [21]. Also, according to manufacturer’s in-
structions in the context of evaluation of fox ORV results
the threshold of positivity of ELISA is decreased from the
70 to 40 %. According to manufacturer’s instructions the
percentage of blocking of 70 % is equivalent to 0.5 IU/ml
obtained with virus neutralisation test. According to that,
the percent of blocking 40 % in ELISA is lower than
0.5 IU/ml obtained with virus neutralisation test. In this
study the purpose of detection of rabies virus antibodies in
the monitoring of fox ORV campaigns was to detect im-
munological response on vaccination but not to consider
the WHO or OIE minimal adequate response (0.5 IU/ml)
[11]. Also, according to previous study the level of anti-
bodies in muscle extracts and haemolytic thoracic liquids
was lower compared to serum samples [4]. Because of the
all above mentioned facts, the threshold of detection of
virus neutralisation test as a part of monitoring of ORV
campaigns was decreased to 0.1 IU/ml in order to establish
the adequate immunological response to vaccination which
can be the proof of seroconversion [20]. However, before
the testing the mFAVN test was validated in comparison to
FAVN test using difference cut-offs. As are recorded in
Table 1 the sensitivity and specificity of the mFAVN
compared with FAVN test were even higher for cut-off
0.1 IU/ml compared to cut off 0.5 IU/ml and show perfect
agreement.
According to results in this study, the agreement
between BioPro ELISA and mFAVN was 89.12 % for
not-heat treated samples, and 87.76 % for heat treated
samples. This means that heat treatment of the samples
has not influence on kappa value of the BioPro ELISA
test. Also, heat treatment of the samples just slightly
increases a diagnostic validity of the test. However, if we
compare an agreement of BioPro ELISA and mFAVN for
thoracic liquids and muscle extracts separately, results
are different.
According to previous study performed on foxes [11]
the agreement between the BioPro ELISA and virus neu-
tralisation test was 95.10 %. In that study thoracic liquid
from the carcasses of the fresh foxes were used as a sam-
ple. In our study samples were not collect from the fresh
foxes and because of that extremely haemolytic thoracic
liquid samples were used for testing. The agreement
between the BioPro ELISA and the mFAVN test was
89.09 % for not-heat treated and 92.73 % for heat treated
samples. So, according to results in our study the quality
Table 2 Results of testing for muscle extracts and thoracic liquids
mFAVN test ELISA ELISA
Not-heat-treated Heat-treated
Positive Negative Positive Negative Positive Negative
Thoracic liquid 38 17 36 19 40 15
Muscle extract 15 77 5 87 23 69
Total 53 94 41 106 63 84
The cut –off for mFAVN test was set on 0.1 IU/ml
The cut –off for BioPro ELISA was set on 40 %
Table 3 Results of sensitivity, specificity, diagnostic agreement and diagnostic validity for BioPro ELISA
All samples Muscle extracts Thoracic liquids
Not-heat treated treated Heat Not-heat treated treated Heat Not-heat treated treated Heat
Specificity 92.98 % 79.10 % 100 % 87.50 % 89.47 % 85.00 %
Sensitivity 79.20 % 96.36 % 60 % 83.33 % 90.00 % 97.43 %
Diagnostic agreement 89.12 % 87.76 % 89.13 % 84.78 % 89.09 % 92.73 %
Diagnostic validity 89.16 % 94.3 % 70.30 % 88.70 % 95.98 % 94.90 %
Confidential interval 0.825–0.958 0.906–0.979 0.519–0.886 0.801–0.973 0.912–1.00 0.888–1.00
Kappa p < 0.001 0.7517 0.7449 0.4560 0.5410 0.7526 0.8240
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of thoracic liquid samples does not have influence on
results obtained with BioPro ELISA or it insignificantly
decreases the agreement between tests. Also, when thor-
acic liquids were used, heat treatment does not increase
the validity of the test.
The opposite situation was recorded when muscle ex-
tracts were used as a sample. Even though diagnostic
agreement between ELISA and mFAVN for heat treated
samples is slightly decreased (4 %) the validity of the test is
significantly increased (18 %). The reason for that is that
according to this study heat treatment of the muscle ex-
tracts causes increase in sensitivity of the test but also
causes decrease in test specificity. This finding is expected
because in general, the higher the sensitivity, the lower the
specificity, and vice versa. However, in this study the im-
provement in sensitivity was significantly higher compared
to specificity decreasing which result in increase of the test
validity. The lower sensitivity when not-heat treated muscle
extracts were used as samples is very important; in that
case a lot of false negative results could be obtained with
ELISA. The reason for different influence of heat treatment
on thoracic liquids and muscle extracts can be explained in
different chemical composition of muscle (enzymes, pro-
teins) compared to blood. Also, the reason for decreasing
of the test specificity can be due to influence of heat treat-
ment on specific antibody structure (proteins) or antibody
activity. However, the influence of heat treatment on test
specificity and sensitivity should be further investigated.
Fig. 1 a Correlation between titres of antibodies (IU/ml) in not-heat treated samples titrated by mFAVN test (cut off was set on 0.1 IU/ml) and
percent of blocking obtained with BioPro ELISA (cut off was set on 40 %). b Correlation between titres of antibodies (IU/ml) in heat treated samples
titrated by mFAVN test (cut off was set on 0.1 IU/ml) and percent of blocking obtained with BioPro ELISA (cut off was set on 40 %)
Fig. 2 a Correlation between titres of antibodies (IU/ml) in not-heat treated thoracic liquids samples titrated by mFAVN test (cut off was set on
0.1 IU/ml) and percent of blocking obtained with BioPro ELISA (cut off was set on 40 %). b Correlation between titres of antibodies (IU/ml) in heat
treated thoracic liquids samples titrated by mFAVN test (cut off was set on 0.1 IU/ml) and percent of blocking obtained with BioPro ELISA (cut off
was set on 40 %)
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According to this study the kappa value ranged between
0.4560 for not-heat treated muscle extract samples to
0.8240 for thoracic liquids heat treated samples. Overall,
the kappa value was significantly lower for muscle extracts
compared to thoracic liquids and indicated only moderate
agreement of the test when muscle extracts were used as
samples. However, the more relevant measure is the test
validity or degree to which the test measures what it
claims to measure. The kappa value only considers the cut
offs but the diagnostic validity considers all results and
provides better overview of test. According to our study
the diagnostic validity for all samples except not-heat
treated muscle extracts was very high (88.70–95.98 %) and
indicated very good reliability of the BioPro ELISA test.
Conclusions
According to this study haemolytic thoracic liquids and
muscle extracts can be used as samples for detection of
specific rabies antibodies with BioPro ELISA. Muscle ex-
tracts samples should be heat treated before testing in
order to increase the validity of the test.
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